Skip to main content
SpringerLink
Log in
Book cover

Therapie der Hautkrankheiten pp 437–457Cite as

Vaskulitis

  • Chapter

  • 93 Accesses

Zusammenfassung

Unter dem klinischen Begriff kutane Vaskulitis wird ein weites Spektrum von Dermatosen verstanden, deren gemeinsames Merkmal histologische Entzündungszeichen an den Hautgefäßen und Veränderungen im umhegenden perivaskulären Gewebe sind.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Boom BW, Mommaas AM, Vermeer BJ (1992) Presence and interpretation of vascular immune deposits in human skin: the value of direct immunofluorescence. J Dermatol Sci 3: 26–34

    Article  PubMed  CAS  Google Scholar 

  • Callen JP (1985) Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 13: 193–200

    Article  PubMed  CAS  Google Scholar 

  • Cupps TR, Fauci AS (1981) The vasculitides. Saunders, Philadelphia, 211 pp

    Google Scholar 

  • DeVita S, Neri R, Bombardieri S (1991) Cyclophosphamide pulses in the treatment of rheumatic diseases: an update. Clin Exp Rheumatol 9: 179–193

    CAS  Google Scholar 

  • Dinarello CA (1992) Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. Semin Immunol 4: 133–145

    PubMed  CAS  Google Scholar 

  • Duquesnoy B (1991) Henoch-Schönlein purpura. Baillieres Clin Rheumatol 5: 253–261

    Article  PubMed  CAS  Google Scholar 

  • Fauci AS, Haynes BR, Costa J et al. (1982) Lymphomatoid granulomatosis. Prospective, clinical and therapeutic experience over 10 years. N Engl J Med 306: 68–74

    Article  PubMed  CAS  Google Scholar 

  • Gaskin G, Savage CO, Ryan JJ (1991) Anti-neutrophil cytoplasmic antibodies and disease activity during longterm follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6: 689–694

    PubMed  CAS  Google Scholar 

  • Horn T (1985) Long-standing erythematous facial plaques: Granuloma faciale. Arch Dermatol 121: 1553–1557

    Article  PubMed  CAS  Google Scholar 

  • James WD, Odom RB, Katzenstein AL (1981) Cutaneous manifestations of lymphomatoid granulomatosis: Report of 44 cases and review of the literature. Arch Dermatol 117: 196–202

    Article  PubMed  CAS  Google Scholar 

  • Katz SI, Gallin JI, Hertz KC et al. (1977) Erythema elevatum diutinum: Skin and systemic manifestations, immunologic studies, and successful treatment with dapsone. Medicine 56: 443–455

    Google Scholar 

  • Longley J, Demar L, Feinstein RP et al. (1987) Clinical and histologic features of pityriasis lichenoides et varioliformis acuta in children. Arch Dermatol 123: 1335–1339

    Article  PubMed  CAS  Google Scholar 

  • McCune WJ, Friedman AW (1992) Immunosuppressive drug therapy for rheumatic disease. Curr Opin Rheumatol 4: 314–312

    Article  PubMed  CAS  Google Scholar 

  • Mertz LE, Conn DL (1992) Vasculitis associated with malignancy. Curr Opin Rheumatol 4: 39–46

    PubMed  CAS  Google Scholar 

  • Mollica F, Li Volti S, Garozzo R, Russo G (1992) Effectiveness of early prednisolone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 151: 140–144

    Article  PubMed  CAS  Google Scholar 

  • Planaguma M, Puig L, Alomar A et al. (1992) Pyoderma gangrenosum in association with erythema elevatum diutinum. Report of two cases. Cutis 49: 201–206

    Google Scholar 

  • Sams WM (1980) Necrotizing vasculitis. J Am Acad Dermatol 3: 1–13

    Article  PubMed  Google Scholar 

  • Sanchez NP, Van Hale HM, Su WPD (1985) Clinical and histopathological spectrum of necrotizing vasculitis: Report of findings in 101 cases. Arch Dermatol 121: 220–224

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson SM, English JSC, Smith NP et al. (1992) Erythema elevatum diutinum: A clinicopathological study. Clin Exp Dermatol 17: 87–93

    Google Scholar 

  • Willemze R (1985) Lymphomatoid papulosis. Dermatol Clin 3: 735–747

    PubMed  CAS  Google Scholar 

  • Horio T, Danno K, Okamoto H et al. (1983) Potassium iodide in erythema nodosum and other erythematous dermatosis. J Am Acad Dermatol 9: 77–81

    Article  PubMed  CAS  Google Scholar 

  • Schafer N, Kerdel FA (1991) Nodular vasculitis (erythema induratum) Treatment with auranofin. J Am Acad Dermatol 25: 426–429

    Article  Google Scholar 

  • Soderstrom RM, Krull EA (1978) Erythema nodosum: a review. Cutis 21: 806–810

    PubMed  CAS  Google Scholar 

  • Ubogy Z, Persellin RH (1982) Suppression of erythema nodosum by indomethacin. Acta Derm Venereol 62: 265–267

    PubMed  CAS  Google Scholar 

  • Upchurch KS, Heller K, Bress NM (1987) Low-dose methotrexate therapy for cutaneous vasculitis with rheumatoid arthritis. J Am Acad Dermatol 17: 355–359

    Article  PubMed  CAS  Google Scholar 

  • Bisalbutra P, Kullavanijaya P (1993) Sulfasalazine in atrophie blanche. J Am Acad Dermatol 28: 275–276

    Article  PubMed  CAS  Google Scholar 

  • Drucker CR, Duncan WC (1982) Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol 7: 359–363

    Article  PubMed  CAS  Google Scholar 

  • Jetton RL, Lazarus GS (1983) Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol 8: 23–26

    Article  PubMed  CAS  Google Scholar 

  • Milestone LM, Braverman IM, Lucky P, Fleckman P (1983) Classification and therapy of atrophie blanche. Arch Dermatol 119: 963–969

    Article  Google Scholar 

  • Purcell SM, Hayes TJ (1986) Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol 14: 851–854

    Article  PubMed  CAS  Google Scholar 

  • Sams MW (1988) Livedo vasculitis. Therapy with pentoxifyllin. Arch Dermatol 124: 684–687

    Article  PubMed  Google Scholar 

  • Sauer GC (1986) Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol 122: 380–381

    Article  PubMed  CAS  Google Scholar 

  • Turner AN, Whittaker S, Banks I (1990) Plasma exchange in refractory cutaneous vasculitis. Br J Dermatol 122: 411–415

    Article  PubMed  CAS  Google Scholar 

  • Alegre VA, Winkelmann RK, Gastineau DA (1990) Cutaneous thrombosis, cerebrovascular thrombosis and lupus anticoagulant–the Sneddon syndrome. Int J Dermatol 29: 45–49

    Article  PubMed  CAS  Google Scholar 

  • Asherson RA, Cervera R (1993) Antiphospholipid syndrome. J Invest Dermatol 100: 21S - 27S

    Article  PubMed  CAS  Google Scholar 

  • Deffer TA, Berger TG, Gelinas-Sorell D (1987) Sneddon’s syndrome. J Am Acad Dermatol 16: 1084–1087

    Article  PubMed  CAS  Google Scholar 

  • Falanga V, Fine MJ, Kapoor WN (1986) The cutaneous manifestations of cholesterol embolization. Arch Dermatol 112: 1194–1198

    Article  Google Scholar 

  • Gollnick H, Cerda JH, Bradac GB (1985) Livedo racemosa generalisata (Ehrmann) mit cerebrovaskulärer Beteiligung ( Herman-Sneddon ). Akt Dermatol 11: 17–21

    Google Scholar 

  • Grattan CE, Burton JL (1991) Antiphospholipid syndrome and cutaneous vasoocclusive disorders. Semin Dermatol 10: 152–159

    PubMed  CAS  Google Scholar 

  • Lubach D, Stamm T, Schwabe C et al. (1990) Livedo racemosa generalisata–an evaluation of thirty-four cases. J Am Acad Dermatol 22: 633–639

    Article  PubMed  CAS  Google Scholar 

  • Naldi L, Locati F, Marchesi L et al. (1993) Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis 52: 219–222

    Article  PubMed  CAS  Google Scholar 

  • Rautenberg W, Hennerici M, Aulich A et al. (1988) Immunosuppressive therapy and Sneddon’s syndrome. Lancet II: 639–630

    Google Scholar 

  • Stephens CJ (1992) Sneddon’s syndrome. Clin Exp Rheumatol 10: 489–492

    PubMed  CAS  Google Scholar 

  • Stockhammer G, Felber SR, Zelger B (1993) Sneddon’s syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke 24: 685–690

    Article  PubMed  CAS  Google Scholar 

  • Zelger B, Sepp N, Stockhammer G et al. (1993) Sneddon’s syndrome: a long-term follow-up of 21 patients. Arch Dermatol 129: 437–447

    Article  PubMed  CAS  Google Scholar 

  • Diaz-Perez JL, Winkelmann RK (1980) Cutaneous periarteritis nodosa: A study of 33 cases. In Wolff K, Winkelmann RK (eds) Major problems in dermatology. Saunders, Philadelphia, 273 pp

    Google Scholar 

  • Goslen JB, Graham W, Lazarus GS (1983) Cutaneous polyarteritis nodosa: Report of a case associated with Crohn’s disease. Arch Dermatol 119: 326–329

    Google Scholar 

  • Guillevin L, Fain O, Lhote F et al. (1992) Lack of superiority of steroid plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss-Syndrom. Arthritis Rheum 35: 208–215

    Article  PubMed  CAS  Google Scholar 

  • Thomas RH, Meyrick, Black MM (1983) The wide clinical spectrum of periarteritis nodosa with cutaneous involvement. Clin Exp Dermatol 8: 47–59

    Article  PubMed  CAS  Google Scholar 

  • Abdullah AN, Keczkes K, Wyatt EH (1989) Skin necrosis in giant cell (temporal) arteritis: Report of three cases. Br J Dermatol 120: 843–846

    Google Scholar 

  • Braun EW, Sams WM, Payne RR (1982) Giant cell arteritis: a systemic disease with rare cutaneous manifestations. J Am Acad Dermatol 6: 1081–1088

    Article  Google Scholar 

  • Doury P, Fabresse FX, Pattin S et al. (1984) La place de la dapsone dans le traitement de la maladie de Horton et de la pseudopolyarthrite rhizomelique. Aim Med Interne (Paris) 135: 31–35

    CAS  Google Scholar 

  • Hall S, Barr W, Lie JT et al. (1985) Takayasu arteritis. A study of 32 North American patients. Medicine 64: 89–99

    Article  PubMed  CAS  Google Scholar 

  • Hitch JM (1970) Dermatologie manifestations of giant-cell (temporal, cranial) arteritis. Arch Dermatol 101: 409–415

    Article  PubMed  CAS  Google Scholar 

  • Hunder GG (1990) Giant cell (temporal) arteriitis. Rheum Dis Clin North Am 16: 399–409

    PubMed  CAS  Google Scholar 

  • Liozon F, Vidal E, Bonnetblanc JM et al. (1986) Disulon in the treatment of Horton’s disease. Experience with 20 patients. Ann Med Interne (Paris) 137: 299–306

    CAS  Google Scholar 

  • Perniciaro CV, Winkelmann RK, Hunder GG (1987) Cutaneous manifestations of Takayasu’s arteritis: A clinicopathologic correlation. J Am Acad Dermatol 17: 998–1005

    Google Scholar 

  • Brandwein S, Esdaile J, Daniff D et al. (1983) Wegener’s granulomatosis: clinical features and outcome in 13 patients. Ann Intern Med 143: 476–479

    Article  CAS  Google Scholar 

  • DeRemee RA, McDonald TJ, Weiland LH (1985) Wegener’s granulomatosis: observation and treatment with antimicrobial agents. Mayo Clin Proc 60: 27–32

    PubMed  CAS  Google Scholar 

  • DeRemee RA, McDonald TJ, Weiland LH (1987) Aspekte zur Therapie and Verlaufsbeobachtung der Wegener’schen Granulomatose. Med Welt 38: 470–473

    Google Scholar 

  • Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85

    PubMed  CAS  Google Scholar 

  • Gross WL, Hauschild S, Schmitt WH (1993) Immunodiagnostische and immunopathogenetische Bedeutung von Anti-Neutrophilen-Cytoplasma Antikörpern. Dtsch Med Wochenschr 118: 191–199

    Article  PubMed  CAS  Google Scholar 

  • Hagen EC, Ballieux BE PB, Daha MR et al. (1992) Fundamental and clinical aspects of antineutrophil cytoplasmic antibodies ( ANCA ). Autoimmunity 11: 199–207

    Google Scholar 

  • Hagen EC, Ballieux BEPB, van Es LA et al. (1993) Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenic consequences. Blood 81: 1996–2002

    PubMed  CAS  Google Scholar 

  • Hu CH, O’Loughlin S, Winkelmann RK (1977) Cutaneous manifestations of Wegener’s granulomatosis. Arch Dermatol 113: 175–182

    Article  PubMed  CAS  Google Scholar 

  • Israel HL (1988) Sulfamethoxazol-trimethoprim therapy for Wegener’s granulomatosis. Arch Intern Med 148: 2293–2295

    Article  PubMed  CAS  Google Scholar 

  • Jayne DR, Davies MJ, Fox CJ (1991) Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 337: 1137–1139

    Article  PubMed  CAS  Google Scholar 

  • Nölle B, Specks U, Lüdemann J et al. (1989) Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 111: 28–40

    Google Scholar 

  • Novack SN, Pearson CM (1971) Cyclophosphamide therapy in Wegener’s granulomatosis. N Engl J Med 284: 938–942

    Article  PubMed  CAS  Google Scholar 

  • Raitt JW (1971) Wegener’s granulomatosis: Treatment with cytotoxic agents and adrenocorticoids. Ann Intern Med 74: 344–356

    PubMed  CAS  Google Scholar 

  • Specks S, Wheatley CL, McDonald TJ et al. (1989) Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener’s granulomatosis. Mayo Clin Proc 64: 28–36

    PubMed  CAS  Google Scholar 

  • Steppat D, Gross WL (1989) Stage-adapted treatment of Wegener’s granulomatosis. First results of a prospective study. Klin Wochenschr 67: 666–671

    Google Scholar 

  • Thomas RH, Payne CM, Black MM (1982) Wegener’s granulomatosis presenting as pyoderma gangrenosum. Clin;Exp Dermatol 7: 523–527

    Article  PubMed  CAS  Google Scholar 

  • Weiner SR, Paulus HE (1989) Treatment of Wegener’s granulomatosis. Semin Respir Med 10: 156–161

    Article  Google Scholar 

  • Chumbley LC, Harrison EG, DeRemee RA (1977) Allergic granulomatosis and angiitis (Churg-StraussSyndrom). Report and analysis of 30 cases. Mayo Clin Proc 52: 477–484

    PubMed  CAS  Google Scholar 

  • Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27: 277–301

    PubMed  CAS  Google Scholar 

  • Crotty CP, DeRemee RA, Winkelmann RK (1981) Cutaneous clinicopathologic correlation of allergic granulomatosis. I Am Acad Dermatol 5: 571–581

    Article  CAS  Google Scholar 

  • Finan MD, Winkelmann RK (1983) The cutaneous necrotizing granuloma (Churg-Strauss syndrome) and systemic disease: review of 27 cases. Medicine 62: 142–158

    Article  PubMed  CAS  Google Scholar 

  • Haas C, Geneau C, Odinot JM (1991) L’angeite allergique avec granulomatose: syndrome de Churg et Strauss. Ann Med Interne (Paris) 142: 335–342

    CAS  Google Scholar 

  • Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 63: 65–81

    Article  PubMed  CAS  Google Scholar 

  • Specks U, DeRemee RA (1990) Granulomatous vasculitis: Wegener’s granulomatosis and Churg-Strauss syndrome.

    Google Scholar 

  • Callen JP, Kalbfleisch S (1982) Urticarial vasculitis: A report of nine cases and review of the literature. Br J Dermatol 107: 87–93

    Google Scholar 

  • Dubost JJ, Souteyrand P, Sauvezie B (1991) Drug-induced vasculitides. Baillieres Clin Rheumatol 5: 119–138

    Article  PubMed  CAS  Google Scholar 

  • Ekenstam EAF, Callen JP (1984) Cutaneous leukocytoclastic vasculitis: Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol 120: 484–489

    Article  Google Scholar 

  • Gibson LE, Su WP (1990) Cutaneous vasculitis. Rheum Dis Clin North Am 16: 309–324

    PubMed  CAS  Google Scholar 

  • Goeken JA (1991) Antineutrophil cytoplasmic antibody — a useful serological marker for vasculitis. J Clin Immunol 11: 161–174

    Article  PubMed  CAS  Google Scholar 

  • Jorizzo JL (1993) Classification of vasculitis. J Invest Dermatol 100: 1065–1108

    Article  Google Scholar 

  • Lancet editorial (1988) Factor VIII related antigen and vasculitis. Lancet I: 1203–1204

    Google Scholar 

  • Lawley TJ, Kubota Y (1990) Vasculitis. Dermatol Clin 8: 681–687

    CAS  Google Scholar 

  • Mackel SE (1982) Treatment of vasculitis. Med Clin North Am 66: 941–954

    PubMed  CAS  Google Scholar 

  • Mader R, Keystone EC (1992) Infections that cause vasculitis. Curr Opin Rheumatol 4: 35–38

    PubMed  CAS  Google Scholar 

  • Monroe EW (1981) Urticarial vasculitis: An updated review. J Am Acad Dermatol 5: 88–95

    Article  PubMed  CAS  Google Scholar 

  • Pusey CD (1990) Plasma exchange in immunological disease. Prog Clin Biol Res 337: 419–424

    PubMed  CAS  Google Scholar 

  • Sanchez NP, Van Hale HM, Su WP (1985) Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases. Arch Dermatol 121: 220–224

    Article  PubMed  CAS  Google Scholar 

  • Smoller BR, McNutt NS, Contreras F (1990) The natural history of vasculitis. Arch Dermatol The antiphospholipid syndrome.Br J Dermatol 125: 199–210

    Google Scholar 

  • Tsokos M, Lazarou SA, Moutsopoulos HM (1987) Vasculitis in primary Sjögren’s syndrome: Histologic classification and clinical presentation. Am J Clin Pathol 88: 26–31

    PubMed  CAS  Google Scholar 

  • Venning MC, Quinn A, Broomhead V, Bird AG (1990) Antibodies directed against neutrophils ( C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med 77: 1287–1296

    Article  PubMed  CAS  Google Scholar 

  • Wolff K, Winkelmann RK (1980) Vasculitis. Saunders, Philadelphia

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Hautklinik und Poliklinik, Klinikum Benjamin Franklin der Freien Universität Berlin, Hindenburgdamm 30, 12200, Berlin, Deutschland

    Prof. Dr. Prof. h.c. Constantin E. Orfanos & Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h.c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (1995). Vaskulitis. In: Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97602-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97602-5_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97603-2

  • Online ISBN: 978-3-642-97602-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation